Page last updated: 2024-08-05 11:44:40
aminotoluene
Any member of the class of toluenes carrying one or more amino groups.
ChEBI ID: 22531
Members (9)
Member | Definition | Role |
---|---|---|
2-methyl-5-(4-methylanilino)-1,3-benzothiazole-4,7-dione | 2-methyl-5-(4-methylanilino)-1,3-benzothiazole-4,7-dione | |
2-toluidine | An aminotoluene in which the amino substituent is ortho to the methyl group. | o-toluidine |
2,4-diaminotoluene | An aminotoluene that is para-toluidine with an additional amino group at position 2. | 2,4-diaminotoluene |
4-methyl-N-(6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepin-3-ylmethyl)aniline | 4-methyl-N-(6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[4,3-a]azepin-3-ylmethyl)aniline | |
4-toluidine | An aminotoluene in which the amino substituent is para to the methyl group. | p-toluidine |
ly3009120 | A member of the class of pyridopyrimidines that is pyrido[2,3-d]pyrimidine substituted by methylamino, 5-{[(3,3-dimethylbutyl)carbamoyl]amino}-4-fluoro-2-methylphenyl, and methyl groups at positions 2, 6 and 7, respectively. It is a potent pan RAF inhibitor which inhibits BRAF(V600E), BRAF(WT) and CRAF(WT) (IC50 = 5.8, 9.1 and 15 nM, respectively). It also inhibits RAF homo- and heterodimers and exhibits anti-cancer properties. | LY3009120 |
N-(4-Methylphenyl)-2,3-dihydro-3-thiophenamine 1,1-dioxide | N-(4-Methylphenyl)-2,3-dihydro-3-thiophenamine 1,1-dioxide | |
N,N'-bis(3-methylphenyl)ethane-1,2-diamine | N,N'-bis(3-methylphenyl)ethane-1,2-diamine | |
N2-(4-methylphenyl)benzene-1,2-diamine | N2-(4-methylphenyl)benzene-1,2-diamine |
Research
Studies (378)
Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
---|---|---|
pre-1990 | 90 (23.81) | 18.7374 |
1990's | 89 (23.54) | 18.2507 |
2000's | 74 (19.58) | 29.6817 |
2010's | 93 (24.60) | 24.3611 |
2020's | 32 (8.47) | 2.80 |
Study Types
Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
---|---|---|
Trials | 3 (0.71%) | 5.53% |
Reviews | 12 (2.84%) | 6.00% |
Case Studies | 2 (0.47%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 406 (95.98%) | 84.16% |